Anapharm Europe validates new LC/MS/MS bioanalytical method for Tiotropium
Anapharm Europe has successfully developed and validated a bioanalytical method for determination of Tiotropium in human plasma by LC/MS/MS. This method with a Limit of Quantification as low as 0.5 pg/mL adds to the list of high sensitivity methods for inhalers, including Fluticasone and Salmeterol.
Challenges in development of robust analytical methods for the quantitation of low molecular weight compounds by LC-MS/MS
Method development can be considered one of the most challenging task in a Bioanalytical laboratory. When working with LC-MS/MS and low molecular weight drugs, low degree of ionization, poor fragmentation, higher presence of isobaric compounds or analyte loss due to their high volatility can get in the way of a successful method development.READ MORE
Qualification of a method for the measurement of a potentially therapeutic protein
A recent project completed by Anapharm involved qualifying an analytical method for the measurement of a therapeutic protein in human skin tissue. The protein of interest is one that is expressed ubiquitously in a number of tissues and cell types.READ MORE
Successful WHO Inspection
Anapharm Bioanalytics is proud to announce that it has successfully undergone World Health Organization GCP/GLP compliance inspection at its Barcelona based bioanalytical labREAD MORE